Profile
MBX VRTX ALNY REGN ARGX SGEN
Company Name MBX Biosciences, Inc. Common Stock Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $327.37M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.04K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Peter Kent Hawryluk MBA Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
MBX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
MBX VRTX ALNY REGN ARGX SGEN
Last Close $9.745 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $25.88 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $5.79 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -62.35 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 68.31 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
MBX VRTX ALNY REGN ARGX SGEN
1 Month Return -33.78 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return -3.51 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return 10.36 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return -51.03 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return -47.12 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return -54.67 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MBX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -79.92 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
MBX VRTX ALNY REGN ARGX SGEN
Asset Growth 219 % -0.87 %
Gross Profit Growth -55.41 % 10.25 %
Revenue Growth - 11.66 %
Revenue 3 Year - 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -93.12 % -93.69 %
Net Income Growth -90.16 % -114.8 %
Net Income 3 Yeari Growth Per Share -126.01 % -122.89 %
Net Income 5 Yeari Growth Per Share -126.01 % -145.38 %
Net Income 10 Yeari Growth Per Share -126.01 % 33.84 %
Operating Income Growth -93.12 % -106.08 %
Operating Cash Flow Growth (CFG) -71 % -113.93 %
Operating 3 Year CFG -125.59 % -118.65 %
Operating 5 Year CFG -125.59 % -131.3 %
Operating 10 Year CFG -125.59 % 12.43 %
EPS Growth -81.37 % -114.8 %
EPS Diluted Growth -81.37 % -114.97 %
Book Value Per Share 438.88 % -6.59 %
Share Holder 3 Year Equity Growth Per Share 676.41 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 676.41 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 676.41 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -47.22 % 116.42 %
Free Cash Flow Growth -73.03 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
MBX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM -74.77 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -33.27 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -31.33 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -39.39 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 88.98 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -38989.19 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -10894.31 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 0.26 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.05 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 9.73 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 0.1 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.12 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -2.14 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 672.44 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -31897.75 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.25 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -10894.31 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -4.57 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -4.6 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -4.6 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
MBX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $-0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 0% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.07B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.06B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.85 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
MBX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.01B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.26B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.21B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.27B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
MBX VRTX ALNY REGN ARGX SGEN
Net Income $-0.06B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.05B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.2
AARD Aardvark Therapeutics, Inc. Common Stock 10.99
ABCL AbCellera Biologics Inc. 4.565
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.635
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.255
ABPWW 0.046281
ABSI Absci Corporation 2.555
ABUS Arbutus Biopharma Corporation 4.425
ABVC ABVC BioPharma, Inc. 2.8645
ABVX Abivax SA American Depositary Shares 81.05
ACAD ACADIA Pharmaceuticals Inc. 24.2
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7602
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.965
ACIU AC Immune SA 2.46
ETFs With Exposure to MBX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00655 238.95
VTI Vanguard Total Stock Market Index Fund 0.00052 325.11
SCHB Schwab U.S. Broad Market ETF 0.000206482 25.4674
SCHA Schwab U.S. Small-Cap ETF 0.00259239 27.755
IWN iShares Russell 2000 Value ETF 0.01345 175.2
IWO iShares Russell 2000 Growth ETF 0.00553 315.02
VXF Vanguard Extended Market Index Fund 0.00216 209.23
HDG ProShares Hedge Replication ETF 0.000890933 51.245
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.65 24.135
UWM ProShares Ultra Russell2000 0.00524878 45.55
VTHR Vanguard Russell 3000 Index Fund 0.00029 291.555
IWC iShares Micro-Cap ETF 0.04523 146.14
URTY ProShares UltraPro Russell2000 0.00376821 51.56
VTWV Vanguard Russell 2000 Value Index Fund 0.01875 155.19
ISCB iShares Morningstar Small-Cap ETF 0.00316 63.39
SBIO ALPS Medical Breakthroughs ETF 0.2 35.64
VTWG Vanguard Russell 2000 Growth Index Fund 0.006 230.75
VTWO Vanguard Russell 2000 Index Fund 0.00911 96.94
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 45.6
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00047 110.68
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.67
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00017 52.47
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00017 52.46
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.45
VTSAX Vanguard Total Stock Market Index Fund 0 158.41
R2US.L SPDR Russell 2000 US Small Cap UCITS ETF 0.0058 70.31
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00199 158.72
VITSX Vanguard Total Stock Market Index Fund 0 158.44
XRS2.F Xtrackers Russell 2000 UCITS ETF 0.00550457 318.35
SC0K.DE Invesco Russell 2000 UCITS ETF 0.0061 104.04
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00199 158.73
RTYS.L Invesco Russell 2000 UCITS ETF 0.0061 123.33
XRSG.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00550457 26146
XRSU.L Xtrackers (IE) Public Limited Company - Xtrackers Russell 2000 UCITS ETF 0.00550457 357.35
ZPRR.DE SPDR Russell 2000 US Small Cap UCITS ETF 0.0058 59.37
R2SC.L SPDR Russell 2000 US Small Cap UCITS ETF 0.0058 51.47
XRS2.DE Xtrackers Russell 2000 UCITS ETF 0.00550457 301.75
JKJ iShares Morningstar Small-Cap ETF 0.00316 231.193
VTS.AX Vanguard US Total Market Shares Index ETF 0.00047 487.64
VEMPX Vanguard Extended Market Index InstlPlus 0.00199 391.7
FESM 0.03 36.075
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00047 297.22
RSSL Global X Funds 0.01 94.045
Unlock